[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Allergy Immunotherapies Market Size, Manufacturers, Opportunities and Forecast to 2030

April 2024 | 63 pages | ID: G911E4BC729AEN
APO Research

US$ 3,450.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.

The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.

According to APO Research, The global Allergy Immunotherapies market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.

In Southeast Asia Allergy Immunotherapies key players include ALK, Stallergenes, etc. Southeast Asia top two manufacturers hold a share about 65%.

Singapore is the largest market, with a share over 30%, followed by Thailand and Malaysia, both have a share about 35 percent.

In terms of product, Subcutaneous Immunotherapy is the largest segment, with a share about 43%. And in terms of application, the largest application is Allergic Rhinitis, followed by Allergic Asthma, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Allergy Immunotherapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Allergy Immunotherapies.

The Allergy Immunotherapies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Allergy Immunotherapies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
  • ALK
  • Stallergenes
  • HAL
Allergy Immunotherapies segment by Type
  • Subcutaneous Immunotherapy
  • Sublingual Immunotherapy
Allergy Immunotherapies segment by Application
  • Allergic Rhinitis
  • Allergic Asthma
  • Other
Allergy Immunotherapies Segment by Region
  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • China Taiwan
  • Indonesia
  • Thailand
  • Malaysia
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Allergy Immunotherapies market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Allergy Immunotherapies and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Allergy Immunotherapies.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2019-2024, 2025-2030). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Allergy Immunotherapies companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

Chapter 12: Concluding Insights of the report
1 MARKET OVERVIEW

1.1 Product Definition
1.2 Global Market Growth Prospects
1.3 Global Allergy Immunotherapies Market Size Overview by Region 2019 VS 2023 VS 2030
1.4 Global Allergy Immunotherapies Market Size by Region (2019-2030)
  1.4.1 Global Allergy Immunotherapies Market Size by Region (2019-2024)
  1.4.2 Global Allergy Immunotherapies Market Size by Region (2025-2030)
1.5 Key Regions Allergy Immunotherapies Market Size (2019-2030)
  1.5.1 North America Allergy Immunotherapies Market Size Growth Rate (2019-2030)
  1.5.2 Europe Allergy Immunotherapies Market Size Growth Rate (2019-2030)
  1.5.3 Asia-Pacific Allergy Immunotherapies Market Size Growth Rate (2019-2030)
  1.5.4 Latin America Allergy Immunotherapies Market Size Growth Rate (2019-2030)
  1.5.5 Middle East & Africa Allergy Immunotherapies Market Size Growth Rate (2019-2030)

2 ALLERGY IMMUNOTHERAPIES MARKET BY TYPE

2.1 Type Introduction
  2.1.1 Subcutaneous Immunotherapy
  2.1.2 Sublingual Immunotherapy
2.2 Global Allergy Immunotherapies Market Size by Type
  2.2.1 Global Allergy Immunotherapies Market Size Overview by Type (2019-2030)
  2.2.2 Global Allergy Immunotherapies Historic Market Size Review by Type (2019-2024)
  2.2.3 Global Allergy Immunotherapies Market Size Forecasted by Type (2025-2030)
2.3 Global Allergy Immunotherapies Market Size by Regions
  2.3.1 North America Allergy Immunotherapies Market Size Breakdown by Type (2019-2024)
  2.3.2 Europe Allergy Immunotherapies Market Size Breakdown by Type (2019-2024)
  2.3.3 Asia-Pacific Allergy Immunotherapies Market Size Breakdown by Type (2019-2024)
  2.3.4 Latin America Allergy Immunotherapies Market Size Breakdown by Type (2019-2024)
  2.3.5 Middle East and Africa Allergy Immunotherapies Market Size Breakdown by Type (2019-2024)

3 ALLERGY IMMUNOTHERAPIES MARKET BY APPLICATION

3.1 Type Introduction
  3.1.1 Allergic Rhinitis
  3.1.2 Allergic Asthma
  3.1.3 Other
3.2 Global Allergy Immunotherapies Market Size by Application
  3.2.1 Global Allergy Immunotherapies Market Size Overview by Application (2019-2030)
  3.2.2 Global Allergy Immunotherapies Historic Market Size Review by Application (2019-2024)
  3.2.3 Global Allergy Immunotherapies Market Size Forecasted by Application (2025-2030)
3.3 Global Allergy Immunotherapies Market Size by Regions
  3.3.1 North America Allergy Immunotherapies Market Size Breakdown by Application (2019-2024)
  3.3.2 Europe Allergy Immunotherapies Market Size Breakdown by Application (2019-2024)
  3.3.3 Asia-Pacific Allergy Immunotherapies Market Size Breakdown by Application (2019-2024)
  3.3.4 Latin America Allergy Immunotherapies Market Size Breakdown by Application (2019-2024)
  3.3.5 Middle East and Africa Allergy Immunotherapies Market Size Breakdown by Application (2019-2024)

4 GLOBAL MARKET DYNAMICS

4.1 Allergy Immunotherapies Industry Trends
4.2 Allergy Immunotherapies Industry Drivers
4.3 Allergy Immunotherapies Industry Opportunities and Challenges
4.4 Allergy Immunotherapies Industry Restraints

5 COMPETITIVE INSIGHTS BY COMPANY

5.1 Global Top Players by Allergy Immunotherapies Revenue (2019-2024)
5.2 Global Allergy Immunotherapies Industry Company Ranking, 2022 VS 2023 VS 2024
5.3 Global Allergy Immunotherapies Key Company Headquarters & Area Served
5.4 Global Allergy Immunotherapies Company, Product Type & Application
5.5 Global Allergy Immunotherapies Company Commercialization Time
5.6 Market Competitive Analysis
  5.6.1 Global Allergy Immunotherapies Market CR5 and HHI
  5.6.2 Global Top 5 and 10 Allergy Immunotherapies Players Market Share by Revenue in 2023
  5.6.3 2023 Allergy Immunotherapies Tier 1, Tier 2, and Tier

6 COMPANY PROFILES

6.1 ALK
  6.1.1 ALK Comapny Information
  6.1.2 ALK Business Overview
  6.1.3 ALK Allergy Immunotherapies Revenue, Global Share and Gross Margin (2019-2024)
  6.1.4 ALK Allergy Immunotherapies Product Portfolio
  6.1.5 ALK Recent Developments
6.2 Stallergenes
  6.2.1 Stallergenes Comapny Information
  6.2.2 Stallergenes Business Overview
  6.2.3 Stallergenes Allergy Immunotherapies Revenue, Global Share and Gross Margin (2019-2024)
  6.2.4 Stallergenes Allergy Immunotherapies Product Portfolio
  6.2.5 Stallergenes Recent Developments
6.3 HAL
  6.3.1 HAL Comapny Information
  6.3.2 HAL Business Overview
  6.3.3 HAL Allergy Immunotherapies Revenue, Global Share and Gross Margin (2019-2024)
  6.3.4 HAL Allergy Immunotherapies Product Portfolio
  6.3.5 HAL Recent Developments

7 NORTH AMERICA

7.1 North America Allergy Immunotherapies Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2 North America Allergy Immunotherapies Market Size by Country (2019-2024)
7.3 North America Allergy Immunotherapies Market Size Forecast by Country (2025-2030)

8 EUROPE

8.1 Europe Allergy Immunotherapies Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2 Europe Allergy Immunotherapies Market Size by Country (2019-2024)
8.3 Europe Allergy Immunotherapies Market Size Forecast by Country (2025-2030)

9 ASIA-PACIFIC

9.1 Asia-Pacific Allergy Immunotherapies Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2 Asia-Pacific Allergy Immunotherapies Market Size by Country (2019-2024)
9.3 Asia-Pacific Allergy Immunotherapies Market Size Forecast by Country (2025-2030)

10 LATIN AMERICA

10.1 Latin America Allergy Immunotherapies Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2 Latin America Allergy Immunotherapies Market Size by Country (2019-2024)
10.3 Latin America Allergy Immunotherapies Market Size Forecast by Country (2025-2030)

11 MIDDLE EAST & AFRICA

11.1 Middle East & Africa Allergy Immunotherapies Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2 Middle East & Africa Allergy Immunotherapies Market Size by Country (2019-2024)
11.3 Middle East & Africa Allergy Immunotherapies Market Size Forecast by Country (2025-2030)

12 CONCLUDING INSIGHTS

13 APPENDIX

13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
  13.5.1 Secondary Sources
  13.5.2 Primary Sources


More Publications